In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer

Ramona Rudalska(STZ eyetrial), Daniel Dauch(STZ eyetrial), Thomas Longerich(Heidelberg University), Katherine McJunkin(Cold Spring Harbor Laboratory), Torsten Wüestefeld(University of Tübingen), Tae-Won Kang(German Cancer Research Center), Anja Hohmeyer(German Cancer Research Center), Marina Pešić(University of Tübingen), Josef Leibold(University of Tübingen), Anne von Thun(Comprehensive Cancer Center Mainfranken), Peter Schirmacher(Heidelberg University), Johannes Zuber(Research Institute of Molecular Pathology), Karl-Heinz Weiss(Heidelberg University), Scott Powers(Cold Spring Harbor Laboratory), Nisar P. Malek(University of Tübingen), Martin Eilers(Comprehensive Cancer Center Mainfranken), Bence Sipos(University of Tübingen), Scott W. Lowe(Memorial Sloan Kettering Cancer Center), Robert Geffers(Helmholtz Centre for Infection Research), Stefan Laufer(University of Tübingen), Lars Zender(German Cancer Research Center)
Nature Medicine
September 13, 2014
Cited by 276Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis